A new study out of Brigham and Women's Hospital shows how newly marketed brand-name drugs in the U.S. are driving up health care spending, resulting in "detrimental effects for patient access and affordability."
Jun 8, 2022
0
1
The gross price of insulin in the U.S. is more than nine times higher than in 33 high-income comparison nations, according to a new RAND report.
Feb 1, 2024
0
1
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together ...
Aug 2, 2013
0
0
Conflict-of-interest statements made by physicians and scientists in their medical journal articles after they had been allegedly paid by pharmaceutical manufacturers as part of off-label marketing programs are often inadequate, ...
Aug 7, 2012
0
0
US authorities on Thursday warned makers of medical devices and hospital networks to step up efforts to guard against potential cyber attacks.
Jun 13, 2013
0
0
On Monday, the U.S. Food and Drug Administration announced it was sending warning letters to 10 manufacturers to stop making products designed to allow youth to vape without getting caught by parents or teachers.
Apr 28, 2020
0
33
What began in the Dentistry lab of Professor Paul Santerre more than a decade ago is now Interface Biologics Inc. (IBI) - a privately-held company poised to transform the market for medical devices in the United States.
Sep 19, 2012
0
0
Eight of the top 10 selling drugs in the United States are biologics, which are produced from living organisms or certain components of living organisms. Subcutaneous injection—where the drug is injected into the tissue ...
Jan 15, 2020
0
0
The antiviral drug tenofovir alafenamide (TAF) has been used since 2015 in different combinations for the treatment of HIV and has already been subject to 3 early benefit assessments for this therapeutic indication. It has ...
Jul 5, 2017
0
0
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute ...
Aug 2, 2013
0
0
